scispace - formally typeset
R

Raymond M. Shaheen

Researcher at University of Texas MD Anderson Cancer Center

Publications -  14
Citations -  2185

Raymond M. Shaheen is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Angiogenesis & Vascular endothelial growth factor. The author has an hindex of 13, co-authored 14 publications receiving 2147 citations.

Papers
More filters
Journal ArticleDOI

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors

TL;DR: It is suggested that DC101 inhibits angiogenesis, endothelial cell survival, and VEGF-mediated ascites formation in a murine model of colon cancer carcinomatosis, and combination anti-VEGF and anti-EGFR therapy may represent a novel therapeutic strategy for the management of colon peritoneal carcinom atosis.
Journal ArticleDOI

Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival.

TL;DR: It is hypothesized that PDGF (platelet‐derived growth factor)‐BB, a cytokine released from tumor and ECs, mediates pericyte function by inducing VEGF, which in turn may affect EC survival.
Journal Article

The Effects of Angiopoietin-1 and -2 on Tumor Growth and Angiogenesis in Human Colon Cancer

TL;DR: The data suggest that imbalances between Ang-1 and -2 that result in a net gain of Ang-2 activity lead to enhanced tumor angiogenesis and growth.
Journal ArticleDOI

Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications.

TL;DR: Results showed that targeting the VEGF receptor/ligand system is a rational approach to inhibiting tumor growth and prolonging survival.